Dr. Sean Conrad is a senior patent agent in the Pittsburgh office. He focuses his practice in the areas of patent preparation, patent prosecution, and client counseling with an emphasis in biotechnology. Sean has prepared and prosecuted patent applications for a range of biotechnologies including: gene therapy, gene editing, CRISPR gene editing, recombinant adeno-associated viruses (AAVs), large molecule therapeutics, immunotherapy, stem cell therapy, biological products, and bioassays. Since 2016, Sean has drafted ~85 patent applications and conducted 8 Landscape/Freedom-to-Operate studies that focus on CRISPR gene editing, one of the hottest areas in biotechnology.
